Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage

F. Maldonado, J. G. Parambil, E. S. Yi, P. A. Decker, Jay H Ryu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Quantification of haemosiderin-laden macrophages in bronchoalveolar lavage fluid (BALF) has been used to diagnose diffuse alveolar haemorrhage (DAH) but has not been assessed in patients with diffuse alveolar damage (DAD). The present study analysed BALF obtained from 21 patients with DAD diagnosed by surgical lung biopsy. The median age of 21 patients with DAD was 68 yrs (range 18-79 yrs); 14 (67%) were male and 12 (57%) were immunocompromised. The median proportion of haemosiderin-laden macrophages in BALF was 5% (range 0-90%), but was ≥20% in seven (33%) patients, fulfilling the commonly used BALF criterion for DAH. There was a trend toward a positive correlation between the percentage of haemosiderin-laden macrophages in BALF and parenchymal haemorrhage assessed semiquantitatively by histopathological analysis. Patients with ≥20% haemosiderinladen macrophages in BALF showed a significantly increased mortality rate (p=0.047) compared to those with <20%. In patients with an acute onset of diffuse lung infiltrates and respiratory distress, ≥20% haemosiderin-laden macrophages in BALF can occur with DAD, and is not necessarily diagnostic of DAH. The finding of ≥20% haemosiderin-laden macrophages in BALF is associated with a worse prognosis in patients with DAD. Copyright

Original languageEnglish (US)
Pages (from-to)1361-1366
Number of pages6
JournalEuropean Respiratory Journal
Volume33
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Hemosiderin
Bronchoalveolar Lavage Fluid
Macrophages
Hemorrhage
Lung
Biopsy
Mortality

Keywords

  • Acute lung injury
  • Alveolar macrophages
  • Bronchoalveolar lavage
  • Haemosiderin

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. / Maldonado, F.; Parambil, J. G.; Yi, E. S.; Decker, P. A.; Ryu, Jay H.

In: European Respiratory Journal, Vol. 33, No. 6, 06.2009, p. 1361-1366.

Research output: Contribution to journalArticle

Maldonado, F. ; Parambil, J. G. ; Yi, E. S. ; Decker, P. A. ; Ryu, Jay H. / Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. In: European Respiratory Journal. 2009 ; Vol. 33, No. 6. pp. 1361-1366.
@article{0e5653f1b67546e59edec206f7a3a554,
title = "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage",
abstract = "Quantification of haemosiderin-laden macrophages in bronchoalveolar lavage fluid (BALF) has been used to diagnose diffuse alveolar haemorrhage (DAH) but has not been assessed in patients with diffuse alveolar damage (DAD). The present study analysed BALF obtained from 21 patients with DAD diagnosed by surgical lung biopsy. The median age of 21 patients with DAD was 68 yrs (range 18-79 yrs); 14 (67{\%}) were male and 12 (57{\%}) were immunocompromised. The median proportion of haemosiderin-laden macrophages in BALF was 5{\%} (range 0-90{\%}), but was ≥20{\%} in seven (33{\%}) patients, fulfilling the commonly used BALF criterion for DAH. There was a trend toward a positive correlation between the percentage of haemosiderin-laden macrophages in BALF and parenchymal haemorrhage assessed semiquantitatively by histopathological analysis. Patients with ≥20{\%} haemosiderinladen macrophages in BALF showed a significantly increased mortality rate (p=0.047) compared to those with <20{\%}. In patients with an acute onset of diffuse lung infiltrates and respiratory distress, ≥20{\%} haemosiderin-laden macrophages in BALF can occur with DAD, and is not necessarily diagnostic of DAH. The finding of ≥20{\%} haemosiderin-laden macrophages in BALF is associated with a worse prognosis in patients with DAD. Copyright",
keywords = "Acute lung injury, Alveolar macrophages, Bronchoalveolar lavage, Haemosiderin",
author = "F. Maldonado and Parambil, {J. G.} and Yi, {E. S.} and Decker, {P. A.} and Ryu, {Jay H}",
year = "2009",
month = "6",
doi = "10.1183/09031936.00119108",
language = "English (US)",
volume = "33",
pages = "1361--1366",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage

AU - Maldonado, F.

AU - Parambil, J. G.

AU - Yi, E. S.

AU - Decker, P. A.

AU - Ryu, Jay H

PY - 2009/6

Y1 - 2009/6

N2 - Quantification of haemosiderin-laden macrophages in bronchoalveolar lavage fluid (BALF) has been used to diagnose diffuse alveolar haemorrhage (DAH) but has not been assessed in patients with diffuse alveolar damage (DAD). The present study analysed BALF obtained from 21 patients with DAD diagnosed by surgical lung biopsy. The median age of 21 patients with DAD was 68 yrs (range 18-79 yrs); 14 (67%) were male and 12 (57%) were immunocompromised. The median proportion of haemosiderin-laden macrophages in BALF was 5% (range 0-90%), but was ≥20% in seven (33%) patients, fulfilling the commonly used BALF criterion for DAH. There was a trend toward a positive correlation between the percentage of haemosiderin-laden macrophages in BALF and parenchymal haemorrhage assessed semiquantitatively by histopathological analysis. Patients with ≥20% haemosiderinladen macrophages in BALF showed a significantly increased mortality rate (p=0.047) compared to those with <20%. In patients with an acute onset of diffuse lung infiltrates and respiratory distress, ≥20% haemosiderin-laden macrophages in BALF can occur with DAD, and is not necessarily diagnostic of DAH. The finding of ≥20% haemosiderin-laden macrophages in BALF is associated with a worse prognosis in patients with DAD. Copyright

AB - Quantification of haemosiderin-laden macrophages in bronchoalveolar lavage fluid (BALF) has been used to diagnose diffuse alveolar haemorrhage (DAH) but has not been assessed in patients with diffuse alveolar damage (DAD). The present study analysed BALF obtained from 21 patients with DAD diagnosed by surgical lung biopsy. The median age of 21 patients with DAD was 68 yrs (range 18-79 yrs); 14 (67%) were male and 12 (57%) were immunocompromised. The median proportion of haemosiderin-laden macrophages in BALF was 5% (range 0-90%), but was ≥20% in seven (33%) patients, fulfilling the commonly used BALF criterion for DAH. There was a trend toward a positive correlation between the percentage of haemosiderin-laden macrophages in BALF and parenchymal haemorrhage assessed semiquantitatively by histopathological analysis. Patients with ≥20% haemosiderinladen macrophages in BALF showed a significantly increased mortality rate (p=0.047) compared to those with <20%. In patients with an acute onset of diffuse lung infiltrates and respiratory distress, ≥20% haemosiderin-laden macrophages in BALF can occur with DAD, and is not necessarily diagnostic of DAH. The finding of ≥20% haemosiderin-laden macrophages in BALF is associated with a worse prognosis in patients with DAD. Copyright

KW - Acute lung injury

KW - Alveolar macrophages

KW - Bronchoalveolar lavage

KW - Haemosiderin

UR - http://www.scopus.com/inward/record.url?scp=69249117384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249117384&partnerID=8YFLogxK

U2 - 10.1183/09031936.00119108

DO - 10.1183/09031936.00119108

M3 - Article

C2 - 19129275

AN - SCOPUS:69249117384

VL - 33

SP - 1361

EP - 1366

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 6

ER -